Literature DB >> 22520800

Patient selection for transcatheter aortic valve implantation: patient risk profile and anatomical selection criteria.

Nicolo Piazza1, Ruediger Lange, Giuseppe Martucci, Patrick W Serruys.   

Abstract

Patient selection plays a crucial role in the success of transcatheter aortic valve implantation (TAVI). It requires meticulous attention to the smallest of details and needs to be performed in a systematic manner for every patient. In essence, the patient must be assessed from access to implantation site. Becoming over "complacent" and "routine" may lead to failure and impact patient safety. TAVI is indicated for high or prohibitive surgical risk patients with severe aortic stenosis. Some patients, however, are too high risk even for TAVI. In addition to patient risk evaluation, anatomical selection criteria need to be considered. Multimodality imaging, using a combination of angiography, echocardiography and multislice computed tomography, is necessary to determine the anatomical suitability for the procedure.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22520800     DOI: 10.1016/j.acvd.2012.02.007

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  9 in total

1.  Imaging for approach selection of TAVI: assessment of the aorto-iliac tract diameter by computed tomography-angiography versus projection angiography.

Authors:  E M A Wiegerinck; H A Marquering; N Y Oldenburger; M A Elattar; R N Planken; B A J M De Mol; J J Piek; J Baan
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-11       Impact factor: 2.357

2.  Vascular complications after transcatheter transfemoral aortic valve implantation: Modified sheath-to-femoral artery ratio as a new predictor.

Authors:  Sinem Çakal; Beytullah Çakal; Oğuz Karaca; Yeliz Güler; Özgür Ulaş Özcan; Hacı Murat Güneş; Filiz Kızılırmak Yılmaz; Arzu Yıldırım; Bilal Boztosun
Journal:  Anatol J Cardiol       Date:  2022-01       Impact factor: 1.596

3.  Practical update on imaging and transcatheter aortic valve implantation.

Authors:  Gisela Feltes; Iván J Núñez-Gil
Journal:  World J Cardiol       Date:  2015-04-26

4.  Prospective evaluation of clinical outcomes in all-comer high-risk patients with aortic valve stenosis undergoing medical treatment, transcatheter or surgical aortic valve implantation following heart team assessment.

Authors:  Christophe Dubois; Mark Coosemans; Filip Rega; Gert Poortmans; Ann Belmans; Tom Adriaenssens; Marie-Christine Herregods; Kaatje Goetschalckx; Walter Desmet; Stefan Janssens; Bart Meyns; Paul Herijgers
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-23

Review 5.  Preinterventional screening of the TAVI patient: how to choose the suitable patient and the best procedure.

Authors:  Crochan J O'Sullivan; Stefan Stortecky; Lutz Buellesfeld; Peter Wenaweser; Stephan Windecker
Journal:  Clin Res Cardiol       Date:  2014-02-11       Impact factor: 5.460

Review 6.  Transcatheter aortic valve implantation.

Authors:  Ahmed Oliemy; Nawwar Al-Attar
Journal:  F1000Prime Rep       Date:  2014-10-01

7.  Predictors of clinical outcome in transfemoral TAVI: circumferential iliofemoral calcifications and manufacturer-derived recommendations.

Authors:  Markus Reinthaler; Sunil K Aggarwal; Rodney De Palma; Ulf Landmesser; Georg Froehlich; John Yap; Pascal Meier; Michael J Mullen
Journal:  Anatol J Cardiol       Date:  2014-04-28       Impact factor: 1.596

8.  TAVR and SAVR: Current Treatment of Aortic Stenosis.

Authors:  Patrick P Hu
Journal:  Clin Med Insights Cardiol       Date:  2012-08-23

9.  Evolution of transcatheter aortic valve implantation over 7 years: results of a prospective single-centre registry of 2000 patients in a large municipal hospital (TAVIK Registry).

Authors:  Gerhard Schymik; Valentin Herzberger; Jens Bergmann; Peter Bramlage; Lars O Conzelmann; Alexander Würth; Armin Luik; Holger Schröfel; Panagiotis Tzamalis
Journal:  BMJ Open       Date:  2018-10-25       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.